A Phase 1/2 clinical trial of Pfizer's vaccine candidate against group B Streptococcus (group B strep or GBS) infection.
Phase of Trial: Phase I/II
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Streptococcal vaccine (Primary)
- Indications Streptococcal infections
- Focus Adverse reactions; Therapeutic Use
- 17 Nov 2016 New trial record